Safe Pro Group (NASDAQ: SPAI), a leader in AI-powered defense solutions, announced the international publication of its patent applications in…
LaFleur Minerals (CSE: LFLR) (OTCQB: LFLRF) (FSE: 3WK0) announced the completion of seven diamond drill holes totaling 1,764 meters at…
Wearable Devices (NASDAQ: WLDS, WLDSW), an award-winning AI-based gesture control technology company, has entered a warrant inducement agreement with an…
Izotropic (CSE: IZO) (OTCQB: IZOZF) (FSE: 1R3), a medical device company advancing imaging technologies for breast cancer detection, has launched…
Survey by Wakefield Research and D-Wave shows 46% of surveyed business leaders expect $1 million to $5 million ROI from…
The trial targets never-smoker non-small cell lung cancer (“NSCLC”) patients, a group with limited treatment options. Japan’s high incidence of…
Wearable Devices (NASDAQ: WLDS, WLDSW), a developer of AI-powered touchless sensing wearables, announced the launch of a military-focused project to…
Lantern Pharma has introduced an AI-powered module within its RADR(R) platform to assess DDA-DDRi combination therapies. The module uses genomic,…
Lantern Pharma (NASDAQ: LTRN) announced that its wholly owned subsidiary, Starlight Therapeutics, has received FDA clearance for an Investigational New…
The FDA-cleared HeartBeam system enables patients and physicians to access significant arrhythmia data outside traditional clinical settings. The HeartBeam system,…